CFTR modulator theratyping: Current status, gaps and future directionsJohn P. Clancy, Katherine L. Tuggle, Donald R. VanDevanter et al.|Journal of Cystic Fibrosis|2018Cited by 288
Prevalence and Clinical Impact of Respiratory Viral Infections from the STOP2 Study of Cystic Fibrosis Pulmonary ExacerbationsChristina S. Thornton, John J. LiPuma, Lindsay J. Caverly et al.|Annals of the American Thoracic Society|2023Cited by 20